Nifty
:
22446.10
Sensex
:
74000.64
43.70 (0.20%)
147.70 (0.20%)
Nifty
Sensex
:
:
22446.10
74000.64
43.70 (0.20%)
147.70 (0.20%)

Astec Lifesciences Ltd.

Pesticides & Agrochemicals

Rating :
30/99

BSE: 533138 | NSE: ASTEC

NSE BSE
1263.25
24-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1266.15
  •  1300.05
  •  1244.50
  •  1264.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  32884
  •  417.74
  •  1541.65
  •  825.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,478.02
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,906.86
  • 0.12%
  • 6.69

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 66.75%
  • 2.03%
  • 19.63%
  • FII
  • DII
  • Others
  • 1.25%
  • 7.79%
  • 2.55%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.74
  • 7.83
  • 4.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.99
  • -0.05
  • -7.31

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.42
  • -6.49
  • -26.76

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.56
  • 34.97
  • 41.58

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.99
  • 6.88
  • 7.66

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.81
  • 8.02
  • 3.60

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
50.79
117.18
-56.66%
110.79
199.75
-44.54%
142.85
184.27
-22.48%
126.97
271.98
-53.32%
Expenses
69.13
105.06
-34.20%
114.21
166.47
-31.39%
139.72
158.82
-12.03%
121.57
206.52
-41.13%
EBITDA
-18.33
12.12
-
-3.42
33.28
-
3.13
25.45
-87.70%
5.40
65.46
-91.75%
EBIDTM
-36.09%
10.35%
-3.09%
16.66%
2.19%
13.81%
4.25%
24.07%
Other Income
0.91
3.79
-75.99%
0.98
3.99
-75.44%
1.71
2.71
-36.90%
2.58
6.80
-62.06%
Interest
6.10
5.88
3.74%
5.99
4.51
32.82%
6.46
3.92
64.80%
6.40
3.32
92.77%
Depreciation
8.70
8.80
-1.14%
9.16
8.17
12.12%
9.39
8.93
5.15%
7.76
10.64
-27.07%
PBT
-32.22
1.24
-
-17.60
24.58
-
-11.01
15.31
-
-6.18
58.30
-
Tax
-7.89
0.39
-
-4.18
6.27
-
-2.82
3.90
-
-1.21
15.24
-
PAT
-24.33
0.85
-
-13.42
18.32
-
-8.19
11.41
-
-4.97
43.06
-
PATM
-47.89%
0.72%
-12.11%
9.17%
-5.73%
6.19%
-3.92%
15.83%
EPS
-12.41
0.43
-
-6.85
9.34
-
-4.18
5.82
-
-2.54
21.97
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
431.40
628.17
676.57
554.87
522.61
430.90
367.58
298.67
246.99
266.88
206.97
Net Sales Growth
-44.20%
-7.15%
21.93%
6.17%
21.28%
17.23%
23.07%
20.92%
-7.45%
28.95%
 
Cost Of Goods Sold
300.19
401.24
386.81
342.05
338.53
279.49
235.05
179.94
160.93
178.74
133.37
Gross Profit
131.21
226.92
289.76
212.82
184.07
151.41
132.54
118.74
86.05
88.14
73.60
GP Margin
30.41%
36.12%
42.83%
38.35%
35.22%
35.14%
36.06%
39.76%
34.84%
33.03%
35.56%
Total Expenditure
444.63
551.91
522.49
443.42
437.43
354.43
298.79
236.27
215.43
212.77
171.60
Power & Fuel Cost
-
45.68
38.04
25.28
28.80
23.80
17.87
15.75
13.84
3.56
6.90
% Of Sales
-
7.27%
5.62%
4.56%
5.51%
5.52%
4.86%
5.27%
5.60%
1.33%
3.33%
Employee Cost
-
52.26
50.31
38.35
29.92
25.10
21.71
20.38
15.89
12.27
11.38
% Of Sales
-
8.32%
7.44%
6.91%
5.73%
5.83%
5.91%
6.82%
6.43%
4.60%
5.50%
Manufacturing Exp.
-
17.95
14.29
12.62
10.16
8.67
7.41
6.67
4.71
0.89
5.61
% Of Sales
-
2.86%
2.11%
2.27%
1.94%
2.01%
2.02%
2.23%
1.91%
0.33%
2.71%
General & Admin Exp.
-
16.77
11.80
9.95
11.27
7.87
8.92
7.86
9.60
9.03
6.55
% Of Sales
-
2.67%
1.74%
1.79%
2.16%
1.83%
2.43%
2.63%
3.89%
3.38%
3.16%
Selling & Distn. Exp.
-
7.51
10.83
6.30
5.58
3.87
5.40
2.91
3.97
5.37
5.32
% Of Sales
-
1.20%
1.60%
1.14%
1.07%
0.90%
1.47%
0.97%
1.61%
2.01%
2.57%
Miscellaneous Exp.
-
10.50
10.40
8.87
13.17
5.63
2.43
2.77
6.49
2.90
5.32
% Of Sales
-
1.67%
1.54%
1.60%
2.52%
1.31%
0.66%
0.93%
2.63%
1.09%
1.19%
EBITDA
-13.22
76.26
154.08
111.45
85.18
76.47
68.79
62.40
31.56
54.11
35.37
EBITDA Margin
-3.06%
12.14%
22.77%
20.09%
16.30%
17.75%
18.71%
20.89%
12.78%
20.28%
17.09%
Other Income
6.18
13.06
10.47
8.03
11.93
11.16
8.11
2.86
7.21
0.93
0.37
Interest
24.95
20.71
9.06
4.75
12.59
12.38
10.66
12.24
12.81
12.84
9.25
Depreciation
35.01
33.65
34.36
25.66
23.16
19.35
14.68
13.68
10.40
12.69
14.77
PBT
-67.01
34.95
121.13
89.07
61.35
55.90
51.56
39.34
15.57
29.52
11.72
Tax
-16.10
9.35
31.24
24.00
13.83
20.14
20.67
9.56
7.36
-2.20
2.50
Tax Rate
24.03%
26.75%
25.79%
26.95%
22.54%
36.03%
37.10%
33.26%
59.26%
-17.49%
22.42%
PAT
-50.91
25.56
89.86
65.05
47.51
35.74
34.91
19.12
4.97
14.77
8.67
PAT before Minority Interest
-50.95
25.59
89.88
65.07
47.53
35.77
35.04
19.18
5.07
14.78
8.65
Minority Interest
-0.04
-0.03
-0.02
-0.02
-0.02
-0.03
-0.13
-0.06
-0.10
-0.01
0.02
PAT Margin
-11.80%
4.07%
13.28%
11.72%
9.09%
8.29%
9.50%
6.40%
2.01%
5.53%
4.19%
PAT Growth
-169.13%
-71.56%
38.14%
36.92%
32.93%
2.38%
82.58%
284.71%
-66.35%
70.36%
 
EPS
-25.97
13.04
45.85
33.19
24.24
18.23
17.81
9.76
2.54
7.54
4.42

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
419.36
396.50
309.18
246.57
202.49
169.65
138.02
118.03
135.34
113.49
Share Capital
19.61
19.60
19.59
19.57
19.55
19.53
19.51
19.46
19.46
18.53
Total Reserves
399.40
376.61
289.18
226.33
182.16
149.23
117.78
97.83
115.88
94.96
Non-Current Liabilities
33.69
38.14
45.99
6.46
9.48
4.86
1.70
6.47
48.94
53.76
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.25
0.40
8.18
12.72
17.64
Unsecured Loans
10.86
0.00
40.00
0.00
0.00
0.00
0.00
0.00
0.50
0.50
Long Term Provisions
0.50
29.06
0.52
0.32
0.23
0.17
0.07
0.45
0.74
0.73
Current Liabilities
526.20
490.59
322.28
318.36
248.80
238.39
193.72
202.97
177.58
117.17
Trade Payables
177.18
189.83
128.18
202.39
63.25
99.93
57.07
68.00
87.84
45.65
Other Current Liabilities
62.99
60.96
46.43
16.72
9.52
13.84
10.16
25.04
7.64
10.28
Short Term Borrowings
285.28
239.37
147.03
98.71
175.67
124.17
126.00
108.57
77.38
57.27
Short Term Provisions
0.75
0.43
0.63
0.54
0.36
0.44
0.50
1.37
4.72
3.96
Total Liabilities
979.44
925.39
677.59
571.72
461.08
413.18
333.59
327.56
361.91
284.46
Net Block
318.47
339.94
212.68
193.62
166.95
115.07
102.94
94.67
133.06
132.23
Gross Block
488.05
477.12
315.53
270.99
221.36
150.15
124.45
105.04
201.03
187.64
Accumulated Depreciation
169.58
137.18
102.85
77.36
54.41
35.08
21.51
10.37
67.96
55.40
Non Current Assets
480.59
409.71
347.16
239.97
212.60
181.50
135.22
136.37
158.40
149.57
Capital Work in Progress
126.60
22.82
115.71
24.11
18.98
41.87
7.56
19.85
12.25
5.84
Non Current Investment
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.01
Long Term Loans & Adv.
35.51
46.94
18.76
22.23
26.67
24.56
21.56
18.05
13.06
11.48
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
3.16
3.80
0.00
0.00
Current Assets
498.85
515.68
330.43
331.75
248.48
231.68
198.37
191.19
203.51
134.90
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.05
Inventories
294.85
186.95
106.09
121.17
92.85
78.48
65.55
71.25
71.93
76.59
Sundry Debtors
154.90
273.63
187.15
160.84
121.81
123.15
110.66
80.61
103.63
51.39
Cash & Bank
2.16
2.13
1.57
1.49
1.48
1.50
4.23
6.05
12.02
4.47
Other Current Assets
46.95
9.85
4.22
6.43
32.34
28.56
17.93
33.27
15.84
2.39
Short Term Loans & Adv.
41.58
43.13
31.39
41.82
30.07
27.28
17.32
31.05
15.30
2.39
Net Current Assets
-27.35
25.09
8.15
13.39
-0.33
-6.71
4.65
-11.79
25.93
17.73
Total Assets
979.44
925.39
677.59
571.72
461.08
413.18
333.59
327.56
361.91
284.47

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
74.66
23.60
-8.16
168.44
15.29
64.67
19.23
-12.53
7.48
14.58
PBT
34.95
121.13
89.07
61.35
55.90
55.71
28.74
12.42
18.98
8.65
Adjustment
50.51
44.02
29.10
37.48
30.35
17.94
34.84
18.77
23.30
24.87
Changes in Working Capital
-5.91
-112.39
-103.32
87.83
-54.54
6.37
-37.69
-38.75
-32.19
-17.02
Cash after chg. in Working capital
79.55
52.75
14.85
186.66
31.71
80.02
25.89
-7.55
10.08
16.50
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.89
-29.15
-23.01
-18.22
-16.42
-15.35
-6.66
-4.98
-2.60
-1.92
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-112.51
-103.87
-73.11
-73.81
-52.50
-48.94
-17.70
-16.05
-19.22
-18.69
Net Fixed Assets
-114.72
-68.70
-136.14
-55.18
-48.32
-60.02
-7.11
79.50
-15.46
-17.12
Net Investments
0.00
0.00
0.06
0.00
0.00
0.00
0.00
0.60
-0.04
-0.03
Others
2.21
-35.17
62.97
-18.63
-4.18
11.08
-10.59
-96.15
-3.72
-1.54
Cash from Financing Activity
37.77
80.48
81.34
-94.53
37.09
-18.25
-0.94
30.68
11.66
3.44
Net Cash Inflow / Outflow
-0.08
0.22
0.06
0.10
-0.12
-2.51
0.60
2.09
-0.08
-0.67
Opening Cash & Equivalents
0.55
0.34
0.31
0.21
0.33
2.84
2.25
0.68
0.78
5.14
Closing Cash & Equivalent
0.47
0.55
0.34
0.31
0.21
0.33
2.84
2.25
0.70
4.47

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
213.72
202.17
157.63
125.66
103.16
86.42
70.36
60.28
69.56
61.25
ROA
2.69%
11.21%
10.42%
9.20%
8.18%
9.38%
5.80%
1.47%
4.57%
3.17%
ROE
6.28%
25.50%
23.46%
21.24%
19.31%
22.90%
15.07%
4.01%
11.88%
7.91%
ROCE
7.75%
22.21%
22.29%
20.44%
20.31%
23.75%
16.08%
10.65%
11.96%
10.88%
Fixed Asset Turnover
1.31
1.72
1.91
2.14
2.32
2.70
2.73
1.61
1.46
1.26
Receivable days
123.89
123.70
113.66
98.14
103.75
115.06
111.38
136.14
99.91
94.59
Inventory Days
139.29
78.67
74.22
74.31
72.56
70.88
79.66
105.79
95.72
105.53
Payable days
166.93
150.04
176.37
112.38
80.55
94.02
100.09
137.14
112.44
87.72
Cash Conversion Cycle
96.26
52.33
11.51
60.07
95.76
91.92
90.96
104.80
83.18
112.40
Total Debt/Equity
0.81
0.71
0.61
0.40
0.87
0.74
0.92
1.08
0.69
0.73
Interest Cover
2.69
14.37
19.75
5.87
5.52
6.23
3.35
1.97
1.98
2.21

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Astec Lifesciences - Quarterly Results
    25th Jan 2024, 16:46 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.